The macrophage: Switches from a passenger to a driver during anticancer therapy.
Publication
, Journal Article
Wang, T; Feldman, GM; Herlyn, M; Kaufman, RE
Published in: Oncoimmunology
December 2015
We have recently discovered that BRAF inhibitors induce potent macrophage responses that confer melanoma resistance to therapy. Our studies lay a foundation for the hypothesis that macrophages switch their role from a passenger to a driver for tumor survival during therapeutic treatment, suggesting that agents that target macrophages can be an important component of "cocktail" anticancer therapy.
Duke Scholars
Published In
Oncoimmunology
DOI
ISSN
2162-4011
Publication Date
December 2015
Volume
4
Issue
12
Start / End Page
e1052929
Location
United States
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1112 Oncology and Carcinogenesis
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, T., Feldman, G. M., Herlyn, M., & Kaufman, R. E. (2015). The macrophage: Switches from a passenger to a driver during anticancer therapy. Oncoimmunology, 4(12), e1052929. https://doi.org/10.1080/2162402X.2015.1052929
Wang, Tao, Gerald M. Feldman, Meenhard Herlyn, and Russel E. Kaufman. “The macrophage: Switches from a passenger to a driver during anticancer therapy.” Oncoimmunology 4, no. 12 (December 2015): e1052929. https://doi.org/10.1080/2162402X.2015.1052929.
Wang T, Feldman GM, Herlyn M, Kaufman RE. The macrophage: Switches from a passenger to a driver during anticancer therapy. Oncoimmunology. 2015 Dec;4(12):e1052929.
Wang, Tao, et al. “The macrophage: Switches from a passenger to a driver during anticancer therapy.” Oncoimmunology, vol. 4, no. 12, Dec. 2015, p. e1052929. Pubmed, doi:10.1080/2162402X.2015.1052929.
Wang T, Feldman GM, Herlyn M, Kaufman RE. The macrophage: Switches from a passenger to a driver during anticancer therapy. Oncoimmunology. 2015 Dec;4(12):e1052929.
Published In
Oncoimmunology
DOI
ISSN
2162-4011
Publication Date
December 2015
Volume
4
Issue
12
Start / End Page
e1052929
Location
United States
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1112 Oncology and Carcinogenesis
- 1107 Immunology